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Dilemma
The prime objective of genome annotation is to relate gene sequences to functional roles. The functional roles are attached to the acronyms that comprise the annotation nomenclature.
Unfortunately, the importance of a logical and universal convention for acronym assignment was not recognized at an early stage, and nomenclature ambiguities are well-embedded in the contemporary literature. Examples include cases where, as a matter of idiosyncratic choice, the same genes from different organisms have been named differently. Alternatively, sometimes entirely different genes carry the same name. In addition, fused genes have often been assigned a single acronym prior to the realization that single genes in other genomes encode the separate domain components of the original multi-domain fusion. Not surprisingly, this has happened often with fused genes in Escherichia coli, an organism studied intensively prior to availability of massive comparative genomic information. The gene-fusion dilemma has generated a particularly large number of annotation mistakes, e.g., where single stand-alone genes have been annotated the same as the wrong fusion member of a two-domain gene. So what to name the newly recognized unfused genes? Clearly, as an initial step of logical naming, some backtracking is in order so that acronym names can be applied at the level of the unfused genes encoding their uni-domain products. (Even with an ideal future of universal nomenclature in place, occasional adjustments might be needed since genes not previously known to be separable may from time to time be found to have divided counterparts in previously unstudied organisms.)
Although increasingly awkward, the various inconsistent and anomalous patterns of acronym usage have been tolerable, because the pool of available model organisms has been relatively small. In the recent past, most of those engaged with the use of particular gene names have, in fact, been the experts and scholars who developed most of the experimental knowledge base. In contrast, the majority of those who access and assign gene names now are annotators and nonexperimentalists who work to assemble and interpret new genomes at global levels. In this era of genomics, the proliferation of pet acronyms is an increasingly less affordable luxury.
There is at least a general level of awareness among an increasingly sophisticated core of database users that they must navigate around the aforementioned problems. But an even more challenging dimension of the nomenclature dilemma stems from complicated (albeit intriguing) relationships between function and protein structure (see Brown et al. [1] and Orengo and Thornton [2] for a perspective.) There is an understandable tendency to suppose that identical functions of proteins must coincide with very similar structures. However, at one extreme, a single functional role may have been captured by unrelated proteins (analogs), i.e., the functional capability evolved independently more than once (convergence). At the other extreme, a single homology group of proteins may be populated with members that possess varied functional roles, e.g., different substrate specificities. Recent reports [3, 4] teach that substrate specificity may vary, sometimes with surprising ease, across a given protein family, but against a backdrop where the basic reaction chemistry deployed within the family is conserved very strongly. Thus, nomenclature assignments can be complicated when guidance for annotation is sought from sequence similarity because completely different structures can evolve to support the same functional roles, yet very similar structures can support different functions.
Our group has been preoccupied with comparative aspects of aromatic metabolism for more than 40 years. Throughout the last decade we have given considerable thought to issues of nomenclature in relationship to what is a relatively large and complex metabolic system. We have implemented a continuum of suggestions [5] [6] [7] [8] [9] [10] [11] [12] , some of which have been further revised or even abandoned in favor of perceived improvements that are presented here. This has at least been a starting point of experience for an issue that is not trivial. Hopefully, our contribution here (which is implemented by a clickable visualization on our website at http://aropath.org/Visualizations/AroPath/AroPath.htm) might provide a blueprint, or at least a sounding board, for the resolution of nomenclature issues at a broader and more global level. Even where the pathway flow of intermediary metabolites is managed by exactly the same reactions, a further aspect of diversity is that these reactions are not necessarily carried out in different organisms by homolog enzymes. Indeed, analog representatives of AroA, AroC, AroE, AroH, PheA, and TrpC are known to exist. In addition, distinct homolog divergence sometimes yields clearly separable sub-homolog groupings. Since appreciation of both the diversity of pathway flow routes and of the enzyme catalysts has been increasingly unmasked by the exponential increase in genome sampling, elucidation of additional diversity can certainly be anticipated.
Results and Discussion
Biochemical diversity
p-Aminobenzoate (PABA) synthesis
Although our analysis does not yet extend to the vitamin-like branches, we include PABA synthase as an exception in Fig. 1 
Functional roles viewed within a context of phylogenetic relationships
The correct inference of functional roles is frustrated, not only by the aforementioned uneven character of the relationships that tie functional roles to enzyme structures, but also by uncertainty about what boundaries of amino-acid identity will guarantee a common functional role [13, 14] .
Indeed, at one extreme, enzymes that exhibit 98% amino-acid sequence identity catalyze different reactions [15] . In spite of these complications, we assert that functional roles can usually be superimposed to hierarchical evolutionary positions within a homologous protein series. But it may be challenging. Consider the case of AroAIα and AroAIβ, which have the same function (DAHP synthase) and share phylogenetic space in the AroAI Superfamily, with both being qualitatively distinct from members of yet another group of DAHP synthases: the analog AroAII Superfamily (Fig. 2) . At the hierarchical level of Iβ proteins, members of AroAIβ are joined by KdsA. (If KdsA, a single cohesive grouping, were being discussed within a context of interest in its phylogenetic relationship with other proteins, it would be more precisely be called KdsAIβ within our scheme.) KdsA proteins have a functional role (KDOP synthase) that differs from that of AroAIβ. In this case, KdsA and AroAIβ (different function) share more overall sequence similarity than AroAIβ and AroAIα (same function). This illustrates a collection of different protein groups that could be susceptible to chaotic annotation, as indeed has been the case, However, once the hierarchical relationships have been discerned following the appropriate exploitation of experimental work, each group can then be appreciated to possess a functional role that is cohesively associated with a particular phylogenetic slice. In other words, the phylogenetic thread can usually be traced with respect to functional roles, even though the thread may have a meandering character. New sequence queries that are addressed to a correct background of annotation will generate the correct functional annotation [9] .
In summary, Fig. 2 gives an example of four distinct groupings that sort out at different hierarchical levels of evolutionary relationship (indicated by the horizontal arrows). The three protein groupings designated at the bottom-left of Fig. 2 are homologs that gather under the Superfamily-I umbrella. Superfamily II, shown at the right, is probably of independent origin. The evolutionary scenario indicated is one that follows the recruitment hypothesis [16] whereby an ancestral 3-deoxy-ald-2-ulosonate phosphate synthase of broad specificity preceded the acquisition (via gene duplication and then differential substrate specialization) of the narrow-specificity enzymes seen in contemporary organisms. The DAHP synthase domain of B. subtilis has greater sequence similarity to the KDOP synthase of E. coli than to the DAHP synthase of E. coli. A single functional role, DAHP synthase (AroA), is represented at multiple (three) phylogenetic-node positions. But once the AroAIα, AroAIβ, and AroAII groups are pinpointed as discrete groupings within their hierarchical boundaries, the functional roles can be correctly fitted to a phylogenetic perspective. Given such insight, new query sequences can be expected to return results that place them within the phylogenetic space defined by the hierarchical boundaries.
Examples are given at the bottom of (ii) Genes in a pathway or pathway segment are named in the order of the reactions catalyzed by the gene products, e.g., AroA, AroB and AroC, which catalyze the first three reactions of aromatic biosynthesis, are encoded by aroA, aroB, and aroC.
(iii) The smallest unit of naming is at the level of discrete catalytic or allosteric domains.
Multi-domain fusions are designated with intervening bullets, e.g., tyrA•aroF encodes fused catalytic domains that abound elsewhere as stand-alone tyrA and aroF domains. Note that a catalytic domain such as TyrA is actually a "supradomain" consisting of an N-terminal cofactor domain and a C-terminal catalytic domain, and potentially these could be named separately. In fact, the cofactor domain [17] is widely distributed in combination with domains other than the TyrA catalytic domain. However, the separate two domains of TyrA are thus far not known to possess any functional roles as independent entities. TyrA catalytic domains always coexist with the cofactor domain to form an intimate functional unit, and the functional site may very well be created between the two domains [18] . In this case, the TyrA name is currently applied to the supradomain, so named as the smallest functional unit at the present time. Hence, in this context of function, we sometimes apply "supradomain" as an equivalent of "domain" in those cases where the smallest functional unit appears to be the supradomain.
Identical functional roles will be associated with identical acronym-proper labels, regardless of whether the gene products are homologs or analogs. On the other hand, note that it is occasionally possible for enzymes catalyzing different reactions to carry the same acronym proper if they are embedded in the same overall metabolic conversion (see rule x).
(iv) If an enzyme consists of subunits, the corresponding gene and gene-product names are designated with additional lower-case letters, e.g., the anthranilate synthase complex consists of the large aminase subunit TrpAa and the small amidotransferase subunit TrpAb, these being encoded by trpAa and trpAb, respectively. If a homology class consists of distinct, well-separated subgroups, additional lower-case Greek subscripts can be appended to designate them, as illustrated by AroAIα and AroAIβ (Fig. 2) . If there were no known analogs, then any well-separated sub-homolog groups would be designated without Roman-numeral subscripts, as is exemplified by TyrAα and TyrAβ. on the one hand, and AroA' and AroB', on the other hand, describe different initial routes that converge to provide exactly the same product (dehydroquinate) to AroC for use as its substrate [19] . Thus, AroA and AroA' each catalyze the first committed step of aromatic biosynthesis in different organisms, but the particular reactions catalyzed are not the same. And the same is true of AroB and AroB'.
Our subsystem coverage does not yet include the large number of connecting links that will be added. Of these, the metabolic linkage to NAD biosynthesis via quinolinate comes to mind because the alternative tryptophan-to-quinolinate and aspartate-to quinolinate pathways [20] will exemplify another instance of pathway convergence to a common intermediate. For example, such a scenario would apply in the situation (see [11] ) where trpD_1 occupies a perfect and complete tryptophan operon in some cyanobacteria, whereas the extraoperonic trpD_2 and trpD_3 paralogs exhibit especially long branches on a protein tree and lack one or more amino-acid residues known to be important for catalysis (thus being likely pseudogenes). In comparisons of the same genes in a collection of organisms where some of the organisms support multiple paralogs and others do not, the single genes cannot properly be labeled the same as a particular paralog member present in a multi-paralog organism. Thus, for example, organisms with a single trpD gene would simply be denoted trpD since the latter has equally orthologous relationships with each of the recent paralogs present in sister organisms [21] . (x) Different substrate specificities of homologs typically support different functional roles in different pathways e.g., the aforementioned DAHP synthase/KDOP synthase dichotomy (Fig. 2 ).
An exception is represented by phenomena where the order of enzymatic reaction steps in a multistep pathway is variable. If homologs having different substrate specificities are embedded within the flow route of the same pathway such that they perform equivalent functional roles at the overall pathway level, they will share the same acronym proper, with the differing specificities indicated with subscript identifiers. This is exemplified by the alternative flow routes between prephenate and L-tyrosine in Fig. 1 . The tyrosine-pathway dehydrogenases catalyze different reactions, being specific for prephenate, for L-arogenate, or able to utilize both.
However, at the broader pathway level, the functional role of each of the three is identical. Namely, in each case the cyclohexadienyl substrate is aromatized via an oxidative reaction that is driven by elimination of the ring-attached carbon dioxide. The three variant specificities are indicated with lower-case, rightward subscripts: TyrAp, TyrAa, and TyrAc, respectively.
If substrate ambiguity of such one-pathway homologs extends to a second substrate, specificity for a second substrate can be designated with leftward subscripts, e.g., NADTyrAp is a tyrosine-pathway dehydrogenase specific for the NAD + /prephenate couple, whereas NADPTyrAa refers to specificity for the NADP + /arogenate couple.
(xi) Genes that encode cleavable signal (or transit) peptides are denoted by leading-asterisk superscripts. Thus, aroHIα encodes cytoplasmic chorismate mutase, whereas *aroHIα encodes periplasmic (or secreted) chorismate mutase.
Overall rationale in support of the acronym scheme. The above nomenclature scheme is intended to relate the acronym library to the evolutionary thread. This is not absolutely necessary to the extent that the single critical need is to implement a consistent, universal assemblage of acronyms. However, a significant advantage of the system proposed is that a given acronym is designed to convey a large amount of biochemical and evolutionary knowledge. Information is otherwise there would be a leading asterisk. It is not a member of a one-function paralog family, otherwise we would see underscore notations. It is not a member of a homolog family that separates into distinct subgroups; otherwise an α, β, etc. would follow the Roman-numeral subscript. XyzCII• has not expanded its functional repertoire by "borrowing" a second functional role that is exercised elsewhere in the lineage by a paralog relative; otherwise the acronym for the "borrowed" functional role of the lost paralog would be applied (with separation by a 'double slash') after that of the surviving paralog. Table 1 and Table 2 show the application of these nomenclature guidelines to the biosynthetic pathways for tryptophan and histidine, respectively. Both pathways exhibit some gene fusions in Esherichia coli, and the fusion designations are illustrated below the tables. Thus, in E. coli, the designation trpAb• indicates that the trpAb domain has a fusion linkage at the C-terminal end, whereas •trpB denotes a trpB domain that carries a fusion linkage at its N-terminus. Likewise, whereas hisH and hisF are free-standing genes in many organisms, they are fused in E. coli (hence being denoted there as hisH•hisF). Both pathways contain enzymes that deploy subunit components: anthranilate synthase (TrpAa and TrpAb), tryptophan synthase (TrpEa and TrpEb), and imidazole glycerol-P synthase (HisEa and HisEb). Each subunit possesses a distinct catalytic function that participates in a more complex overall reaction.
Nomenclature that anticipates future changes
The tryptophan [22] and histidine [23] pathways have long enjoyed status as model pathways in model organisms, and it was generally assumed for many years that these pathways as summarized in Table 1 and Table 2 were universal. However, in the recent genomic era some unexpected variations have surfaced, and more can be anticipated. Tables 3 and 4 (and the immediately following discussion) illustrate how the new variations can be accommodated to the rules of nomenclature suggested herein.
Tryptophan biosynthesis updated
In Actinomycete bacteria related to Mycobacterium, trpC (encoding phosphoribosyl-anthranilate isomerase) is absent from the genome. The function of the missing enzyme has in fact been captured by HisD, which also functions as the phosphoribosyl isomerase in the histidine pathway [24] . This breadth of isomerase specificity is unusual because contemporary HisD proteins are generally specific for the isomerase reaction in the histidine pathway. Since broadened isomerase specificity is seen to be achievable, it is tempting to wonder if HisD and TrpC are, in fact, homologs (i.e., paralogs that arose from an ancient common ancestor having broad substrate specificity). If so, this is masked by substantial divergence. With this finding in Actinomycete bacteria, the previously known classical trpC (of Table 1 ) becomes trpCI in Table 3 , and the newly discovered trpC found in Actinomycetes is denoted hisD // trpCII (see rule ix).
In another example of paralog loss accompanied by the rescue of its function by a surviving sister paralog to yield a bifunctional enzyme, Bacillus subtilis and a small clade of close relatives possess a bifunctional pabAb // trpAb gene [25, 26] . Contemporary PabAb and TrpAb proteins are different-function homologs that are difficult to discriminate on the criterion of amino acid sequence because they fail to separate into two distinct and cohesive subclusters on a phylogenetic tree. Fortunately, however, trpAb can be presumed to be the lost paralog in the latter case because the surviving paralog gene is located in the pab operon [25] . Therefore, we name the surviving paralog gene pabAb // trpAb. (pabAb appears first and in bold fonts because it is the surviving paralog, one that has additionally acquired the closely related function that is shown second.) It is interesting to consider that paralog loss and broadened substrate specificity of the surviving paralog may, in fact, be a reversal of the steps of gene duplication and divergent paralog specialization envisioned to be a general evolutionary scenario [16] .
Finally, among prokaryotes we recently analyzed a distinct second subcluster of TrpEb that has a widespread, but erratic, distribution. This relatively rare species has been denoted TrpEb_2 to distinguish it from the typical form, called TrpEb_1 [12] . According to the bottom section of rule vi, TrpEb_1 and TrpEb_2 can better be named TrpEbα and TrpEbβ, respectively (Table 3) another [12] that differ from the classical ones established between TrpEaα and TrpEbα [27] .
(ii)
In other cases TrpEbβ co-exists with TrpEbα. Since the latter is undoubtedly the competent functional subunit of tryptophan synthase, the function of the former is a matter of speculation. If the idea is affirmed that these TrpEbβ proteins have captured the function of a lost homolog (serine deaminase) as proposed by Xie et al. [12] , they would be renamed TrpEbβ // SdaII. The primary serine deaminase elsewhere in the lineage (but missing in the organisms having both TrpEbα and TrpEbβ would then be named SdaAI. If this were to prove correct, it would appear that one way (bioinformatic) to differentiate TrpEbβ from TrpEbβ // SdaII is that the former will coexist uniquely with the distinctive set of TrpEaβ subunit partners.
Histidine biosynthesis updated
The first enzyme of histidine biosynthesis is a highly regulated phosphotransferase that is unrelated to other classes of phosphotransferases. It has recently been found that feedback inhibition is accomplished in two very distinct ways. Some organisms have a "short" version of HisA (recently called HisGs) that requires another subunit (recently called HisZ), a homolog of class II aminoacyl-tRNA synthetases, for both activity and feedback inhibition [28] . We name these subunits HisA and HADI (Table 4) . HAD denotes 'histidine allosteric domain'. Since HADI does not appear to have a distinct catalytic role, rule iv is not invoked to name it HisAb in combination with HisA (which would then be named HisAa). HADI is probably required for catalytic activity because it stabilizes HisA.
In other organisms a "long" form of HisA exists (recently called HisGL). This is the classical enzyme of such organisms as E. coli. HisGs and the N-terminal portion of HisGL are homologous.
Approximately the C-terminal 100 amino-acid residues of HisGL are unique and constitute a domain that is asserted to be an allosteric domain accomplishing feedback inhibition ( [29] and references therein). We propose to name this protein HisA•HADII. Thus, HADI and HADII can be viewed as analogs that have converged to impart allostery to HisA: HADI via complex formation and HADII via gene fusion.
Prokaryotes that mobilize a HisG homolog for aromatic aminotransferase function usually possess two differentially specialized paralog genes, one (hisG) that typically is within a histidine operon and the other (aroJIβ) located elsewhere. hisG and aroJIβ were previously called hisHn and hisHb in order to connote their properties of narrow specificity and broad specificity [8] . A few organisms are known where a single aroJIβ gene fulfills a dual function in both histidine and aromatic biosynthesis. Thus, the surviving AroJIβ paralog has captured the histidine-pathway function of the lost HisG paralog. In B. subtilis aroJIβ // hisG) is within a mixed-function supraoperon [26, 30] that also contains tyrA.
The common-pathway reactions to prephenate Table 5 shows the nomenclature of gene/protein families with respect to the seven commonpathway steps of chorismate biosynthesis and, in addition, chorismate mutase (the initial step common to PHE and TYR biosynthesis). The far-left column includes broad catalytic roles that may include different analog types. If so, the analog groupings are shown as Superfamilies in the next column to the right. We have been conservative here. For example, on structural grounds MurA and AroF [31] may very well be distant homologs, as is also the case for the AroHI and AroHIII pair [32] . Bold type indicates specific function in aromatic biosynthesis, and the steps are named in the fourth column in the order of reaction sequences in the pathway, i.e., AroA, AroB, etc. Other homolog relatives that possess different functions are also shown in order to illustrate functional roles in a context of broad evolutionary relationships. In addition, it is of interest that a functional role of one grouping sometimes has the potential to be extended to nearby homolog relatives via "suppressor" mutation(s).
AroA. In the first section of Table 5 AroA is seen to separate into two distinct analog groups of 3-deoxy-ald-2-ulosonate phosphate synthases at the level of Superfamily, one of which is further subdivided (recall the previous presentation in Fig. 2 AroB. AroB has no known analog relatives that exercise the function of DAHP cyclization, the generally present second step of chorismate biosynthesis. It is interesting that two other carbocyclases exist as distant homologs. 2-Deoxy-scyllo-inosose (DOI) synthase from Bacillus circulans catalyzes the carbocycle-forming reaction from glucose 6-P as an initial step of antibiotic formation [33] . ValA, the initial enzyme of validamycin antibiotic biosynthesis in Streptomyces hygroscopicus utilizes D-sedoheptulose 7-phosphate in a comparable carbocycle-forming reaction [34] .
AroA' and AroB'. In some Archaea and in a few Bacteria, aromatic biosynthesis is initiated with completely different substrates than are used in the classical biosynthesis scheme. This is a most striking recent discovery by a single author [19] . Here L-aspartate semialdehyde and 6-deoxy-5-ketohexose 1-phosphate are condensed by AroA' to form 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate. This is utilized by AroB', which catalyzes both oxidative deamination and carbocyclase reactions to produce dehydroquinate. This is then the point of convergence of the novel pathway with the classical pathway. The discovery of a completely different interface of carbohydrate metabolism with aromatic biosynthesis sets the stage for intriguing new metabolic insights.
AroC. AroC is represented by two broadly distributed analogs: AroCI and AroCII. In the reverse direction, dehydroquinase can function for catabolism of shikimate and/or quinate. Although AroCI has frequently been referred to as "biosynthetic dehydroquinase" and AroCII as "catabolic dehydroquinase", it would appear that AroCII functions in the biosynthetic direction about as often as AroCI. Although E. coli was demonstrated to use AroCI for biosynthesis at an early time, most enteric bacteria (even ones as close to E. coli as Klebsiella and Yersinia) deploy AroCII for biosynthesis (deduced because AroCII is the sole species of AroC present in these genomes).
Pseudomonas aeruginosa possesses two paralogs of AroCII, one engaged in biosynthesis and the other in catabolism [5] , etc. Bacillus subtilis employs AroCI for biosynthesis and AroCII for catabolism.
AroD.
As is the case with AroC, the shikimate/quinate dehydrogenases function in the forward direction for biosynthesis and in the reverse direction for catabolism of shikimate and/or quinate.
Quinate, in particular, is one of the most abundant sources of carbon and energy on the planet [35] .
The Superfamily-I enzymes are NAD(P)-dependent dehydrogenases, whereas the analogs that populate Superfamily-II are membrane-associated dehydrogenases that use pyrrolo-quinolinequinone as the cofactor instead. The latter is a catabolic quinate dehydrogenase. AroD members (the α Subfamily) do not utilize quinate and are strictly specific for NADPH, as expected for a reductive step in biosynthesis. YdiB, in contrast, is a catabolic enzyme that can use either of the oxidized cofactors, as well as either shikimate or quinate. SDH-L is specific for shikimate and NADP, similar to AroD, but it has been speculated to provide some other unknown function [36] .
Reversed order of reactions AroC and AroD in some lineages? Dehydroquinate is converted
to shikimate via a dehydratase reaction and a dehydrogenase reaction. It has been pointed out that these reactions could easily occur in either order, as well as that the individual alternative reactions have been demonstrated [35, 37] . As illustrated in Fig. 3 Fig. 3 . The state of knowledge here can be compared to a time prior to the finding that arogenate dehydrogenase existed as a potential alternative to prephenate dehydrogenase in nature [38] .
AroE. There are two analog types of AroE (shikimate kinase). AroEI is generally related to NMP kinases, whereas AroEII is generally related to GHMP kinases ( Table 5 ). The bioinformatic framework of logic and the experimental followup to demonstrate AroEII is a premier example of new-gene discovery in the genomic era [39] . AroEII is thus far restricted to Archaea in its distribution. It is interesting that AroEI and AroEII illustrate a case where two analogs share the same convergently evolved substrate specificity, yet each is related to subsets within their own homology groups that exhibit different substrate specificities. This is entirely reminiscent of the situation presented in Figure 2 .
AroF. AroF is a highly conserved enolpvruvyl transferase (Superfamily I) that might be distantly related to the MurA type of carboxyvinyl-transferase (Superfamily II) that participates in cell wall biosynthesis [31] .
AroG. Chorismate synthase (AroG) exhibits a structure that thus far shows no similarity to any other structurally characterized protein [40] . Chorismate synthase has an absolute requirement for reduced FMN. At the enzymological level, Neurospora crassa and Saccharomyces cerevisiae have a "built-in" NADPH:FMN oxidase activity that is usually supplied externally by other organisms.
A basis for this difference at the level of amino-acid sequence is not yet apparent.
AroH. Chorismate mutases supply the phenylalanine and tyrosine branches with prephenate.
Chorismate mutases are distributed throughout an assemblage designated in Table 5 as having cyclohexadienyl mutase as the broad catalytic activity. The cyclohexadienyl mutases are represented by three analog Superfamilies: AroHI, AroHII and AroHIII. Crystal structures have been presented for each: AroHI from Escherichia coli [41] , AroHII from Bacillus subtilis [42] , and AroHIII from yeast [43] . AroHI and AroHII are small prokaryote sequences, with AroHI having the broadest distribution. Some organisms possess both AroHI and AroHII simultaneously, e.g.
Bacillus subtilis.
AroHIII is much larger than AroHI and AroHII due to the presence of a complex allosteric region that interacts with all three aromatic amino acids, tryptophan being an activator, and tyrosine and phenylalanine being inhibitors. Valid support has been presented on structural grounds that AroHI and AroHIII could be distant homologs [32] , but we take a conservative stance on this point for the present. AroHI subdivides into a number of families, some of which have different functional roles. PchB utilizes isochorismate instead of chorismate, and functions in pyochelin biosynthesis. PapB functions in p-amino-phenylalanine biosynthesis, a step needed for antibiotic synthesis [44] . However, PchB is known to have weak activity as chorismate mutase [45] . *AroHI is a novel chorismate mutase that has a signal peptide which mobilizes it to the periplasm for some unknown function [5] .
Note that AroHI is fully described as AroHIα (Table 5 ). However, since other families, except *AroHI, do not exhibit chorismate mutase function, it is unnecessary to use the Family descriptor. 
Phenylalanine and Tyrosine Branches
The pathway branches that lead from prephenate to L-phenylalanine and from prephenate to Ltyrosine exhibit a phenomenon in which the overall multi-step chemistry is identical; yet this is Rule x applies to aromatic-pathway dehydrogenases because, regardless of specificity differences they perform the same overall function of decarboxylation and aromatization in L-tyrosine biosynthesis. Likewise rule x applies to aromatic-pathway dehydratases because, regardless of specificity differences, they perform the same overall function of decarboxylation, dehydration, and aromatization in L-phenylalanine biosynthesis. Aromatic aminotransferases generally contribute to both phenylalanine and tyrosine biosynthesis. And again, regardless of the reaction order with respect to the functional linkage with aromatic-pathway dehydratases or dehydrogenases, the overall function is the same, namely to convert the ring-attached pyruvyl moiety to an alanyl moiety. Likewise, cyclohexadienyl dehydratase functions as either prephenate dehydratase or arogenate dehydratase (depending upon relative substrate availability). In many organisms it is quite likely that a mixture of both flow routes to phenylalanine and/or tyrosine is ongoing at the same time.
Cyclohexadienyl dehydrogenases are very closely related to prephenate-specific dehydrogenases and to arogenate-specific dehydrogenases, and sequence motifs that predict the various profiles of substrate specificity are not yet worked out [47] . We suspect that changes in specificity have occurred independently so many times that it will be difficult to unravel the evolutionary thread without analysis of many very closely related organisms.. The comparable situation appears to apply to the set of phenylalanine-pathway dehydratases.
Hence, regardless of whether the dehydratase or dehydrogenase reactions are the first or second steps proceeding from prephenate, the acronym proper applied is PheA or TyrA, respectively. In each case, the companion step is a broad-specificity aminotransferase belonging to one of at least three homology subdivisions. The application of the AroJ acronymn for aromatic aminotransferases reflects the sense that they can be viewed as an extension of the commonpathway assemblage that is sidetracked only by the dehydratase /dehydrogenase divergence. The aromatic aminotransferases belong equally to phenylalanine and tyrosine biosynthesis in that they have an affinity for a cyclohexadienyl or aromatic ring possessing a pyruvyl sidechain, which is converted to an alanyl sidechain. Phenylalanine and tyrosine biosynthesis deploy in common all of the enzyme reactions represented by AroA through AroH, as well as AroJ. Only the PheA/TyrA diversion accounts for the ultimate production of two different amino acids, differing only in the presence of a 4-hydroxy substituent at the 4-position of the aromatic ring.
Aromatic aminotransferases.
Aromatic aminotransferases belong to a large and ancient lineage that has been well studied [48] . Tracking back to the deepest level is the "Alpha division of PLPdependent proteins. Splitting from this is the "Aminotransferase superfamily". One of four divergences yields the "Family I aminotransferases". Different suites of signature amino-acid motifs have been discerned at each of the latter hierarchical levels. In addition, Jensen and Gu [8] have sorted out seven subfamilies within aminotransferase Family I. This is based upon motifs that exhibit differing patterns of conservation distributed around the 11 invariant anchor residues of Family I. Specificity for transamination of aromatic amino acids is thus far known to be represented by members within three of the seven Subfamilies (See Table 6 ). Subfamily Iα generally contains aspartate aminotransferases of varied breadth of substrate specificity. E. coli
TyrB is a broad-specificity variant of AspC that is specialized for function as aromatic aminotransferase, largely because it has been captured by the tyrR regulon [49] . Subfamily Iβ consists of two distinctly diverged clusters of imidazoleacetol-P aminotransferase. One (HisG) has narrow specificity and is frequently encoded by a gene present in the histidine operon. The other (AroJIβ) has a broad-substrate capability to function as an aromatic aminotransferase. Finally, Subfamily Iγ contains aminotransferases of varied function, some of which can function as aromatic aminotransferases [50] .
Given the states of broad substrate specificity and free reversibility of reaction that typify aminotransferases, the in vivo functional roles are heavily orchestrated by particular modes of regulation. Thus, PhhC from Pseudomonas aeruginosa exhibits in vitro properties that are very similar to the E. coli paralogs AspC and TyrB. Whereas AspC functions as a fundamental aspartate aminotransferase, TyrB and PhhC are effectively specialized by the regulation schemes in place.
Thus, tyrB is a member of the large tyrR regulon that regulates aromatic biosynthesis [49] , and phhC is a member of the phenylalanine hydroxylase operon regulated by phhR [51] . It is instructive that a mutational deficiency of aspC in E. coli can be suppressed by tyrB, provided that the regulatory constraints normally imposed upon tyrB are removed [52] . Aminotransferases typically are freely reversible reactions. Aromatic aminotransferases can be expected to work in a biosynthetic direction if phenylalanine or act as a repressor, and to work in the catabolic direction and if phenylalanine or tyrosine acts as an inducer.
Tyrosine biosynthesis. Considerable bioinformatic analysis of tyrosine biosynthesis has been published recently [47] . All biosynthetic dehydrogenases performing the critical step of aromatization and decarboxylation belong to the single TyrA Superfamily. Within this Superfamily there is a great deal of diversity with respect to the specificity for both the cyclohexadienyl substrate and for the pyridine nucleotide substrate. Acronyms used to describe
TyrA specificity patterns are given in Table 7 . Thus far, amino-acid sequence motifs that correlate reliably with sequence specificities have not been determined, and it may be that multiple combinations of active-site combinations can lead to similar substrate-specificity profiles. A comparison of X-ray crystal structures from proteins representing differing substrate specificities is badly needed. Good choices would be that from Bacillus subtilis [53] (absolutely specific for prephenate) and that from Synechocystis [54] (absolutely specific for arogenate). A recent crystal structure has been completed [18] for the TyrA protein from Aquifex aeolicus, which is an NAD + -dependent cyclohexadienyl dehydrogenase that exhibits a great preference for prephenate over Larogenate.
A recent analysis has identified a large number of "cohesion groups", whose members are congruent with 16S rRNA expectations, except for occasional "intruders" (probable LGT events implied). The phylogenetic orientation of cohesion groups with one another on the protein tree is uncertain because of insufficient bootstrap support. However, these cohesion groups (which can be viewed at http://aropath.org/TyrPath/TyrCG_index.html) are expected to merge as new sequences become available to fill phylogenetic gaps. TyrA cohesion groups fall into two distinct protein families, termed TyrAα and TyrAβ. The larger TyrAα family includes the majority of bacterial TyrA cohesion groups, whereas the TyrAβ family includes the Archaea and some
Bacteria. Strikingly, the assemblage of lower-gamma Proteobacteria belong to the TyrAβ family, whereas the upper-gamma Proteobacteria and all other Proteobacteria belong to the TyrAα Family.
We speculate that the TyrAβ family is distinguished by indel alterations that are associated with functional interactions of the TyrA domain with another domain, e.g., with the N-terminally fused AroHI domain in E. coli.
Phenylalanine biosynthesis. Phenylalanine-pathway dehydratases fall into two classes (Table 8 ).
The widely distributed PheAI•ACT has a cytoplasmic location in prokaryotes (and a plastid location in higher plants). The narrowly distributed *PheAIIc has a cleavable signal peptide and is translocated to a periplasmic location in Gram-negative bacteria or is apparently secreted in Grampositive bacteria. It seems likely that *PheAIIc (as well as *AroHI and *AroJIβ) perform some sort of role in secondary metabolism, rather than exerting a role in primary biosynthesis.
Superfamily-I dehydratases, denoted as PheAIp•ACT, are typically specific for prephenate and possess a C-terminal ACT domain that is responsible for complex patterns of allosteric inhibition and activation [55] . The probable loss of allostery following point mutations in the Buchnera sp.
PheAIp•ACT is an interesting case of endosymbiont innovation to provide the host with an unregulated supply of phenylalanine [56] . Relatively few organisms known to utilize an arogenatespecific dehydratase have genome sequences available, but among the complete genomes, It is interesting that two small subgroups diverge from the main *PheAIIc cluster because this might prove to reflect narrowed substrate specificities for prephenate (in which case the acronym would be *PheAIIp) or for L-arogenate (in which case the acronym would be *PheAIIa).
Different-function homolog sequences that crowd a common phylogenetic space
A difficult dilemma of acronyn usage occurs when sequences conferring different function crowd the same phylogenetic space. This is because without a clean correlation of functional divergence and sequence divergence, the sorting of functional roles can be quite challenging. Similarly, the substrate specificity of TyrA proteins, whether they be specific for prephenate (TyrAp), specific for L-arogenate (TyrAa), or broadly specific (TyrAc), cannot be correlated with homology sub-clusters or discerned by any known motifs at the present time. The PheA proteins have been less heavily studied, but again the substrate specificities of PheAI proteins, whether specific for prephenate or specific for L-arogenate, cannot be predicted at present from sequence comparisons. Broad-specificity enzymes of the PheAI homology class (cyclohexadienyl dehydratase) are not currently known, although it seems likely that they exist. Only broadspecificity cyclohexadienyl dehydratase is known to populate the PheAII homology class at present, but the great majority of sequences now available have not been studied experimentally.
It would not be surprising if these prove to include prephenate-specific and arogenate-specific enzymes in addition to the cyclohexadienyl dehydratases.
The ease of tracking nodes of function along the evolutionary thread can be expected to vary with the degree of sequence conservation that is typical of a given enzyme reaction. For those reactions which exhibit considerable plasticity, being prone to facile changes in substrate recognition, a more highly refined scale of analysis is necessary. That is, one must zoom in on more sequences from a more compressed phylogenetic slice of organisms. The substrate specificities of TyrA proteins exemplify a scenario where divergence to a given specificity appears to have occurred independently and via different combinations of mutations on many occasions. Given sufficient experimental information with organisms having appropriate phylogenetic spacing, it should be possible to identify multiple nodes of specificity that are reminiscent of those shown in Fig. 2 (albeit more complicated).
Figures Fig. 1 . Biochemical pathway of aromatic amino acid biosynthesis. The segments discussed herein are the "common" pathway linking carbohydrate metabolism to chorismate, the tryptophan branch, the single step from chorismate to prephenate, the phenylalanine branch, and the tyrosine branch. reaction. In the bottom route (as discussed by Jensen et al. [37] , by Bonner and Jensen [35] , and refs. therein) a dehydrogenase functions first, followed by a dehydratase reaction. These two routes produce dehydroshikimate and quinate as unique intermediates of a two-step overall conversion that is otherwise identical. Table 1 is given in the first column, and is renamed (usually), as shown directly across from it in the second column. Acronyms of newly recognized genes having the same function are shown on the bottom line of each block. Table 2 is given in the first column. The new name, when applicable, is presented directly across from it in the second column. Acronyms of newly recognized genes having the same function are shown on the bottom line of each block. b Haemophilus influenzae possesses two paralogs of the HisG aminotransferase: one of narrow specificity for imidazoleacetol-P (HisG) and the other of broad specificity that can also function as aromatic aminotransferase. (Bacillus subtilis and close relatives lack the typical omnipresent, operon-bounded, narrow-specificity species of HisG, and the remaining broad-specificity AroJβ // HisG functions for both histidine and aromatic biosynthesis.)
Tables
c See Rijnen et al. [50] . 
